Provides guidance on the route of administration (intravenous only), management, monitoring and safety considerations related to the risk management plan.

Provides help to patients to understand the risks associated with Ruxience and reminds them to seek immediate medical attention if they experience any of the listed signs and symptoms.

Provides information to patients on the risks, signs and symptoms of infection and the need to contact their doctor immediately if they experience them.